Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1989-7-13
|
pubmed:abstractText |
Eleven parkinsonian patients participated in a pharmacokinetic/pharmacodynamic study in an attempt to model levodopa (L-DOPA) plasma concentrations to clinical effect. Carbidopa 25 mg/L-DOPA 100 mg (Sinemet 25/100) was given orally, and blood samples were obtained before and serially for 4 hours after the dose. Effect measurements were obtained with each blood sample and included tapping score, timed walking, and global assessment of motor function. Mean L-DOPA plasma concentrations were fitted to a one-compartment pharmacokinetic model. A time-wise plot of modeled plasma L-DOPA concentrations versus mean effect measurements revealed a counter-clockwise hysteresis. Effect compartment concentrations were determined by a least squares approach, which determined elimination rate constants by minimizing hysteresis. Half-times for the equilibration between plasma and the effect compartment were 0.39 h for tapping, 0.36 h for walking, and 0.34 h for the global score. Pharmacodynamic data were fit best with an Emax model with baseline effect for tapping (Emax = 53.2 taps/60 s, EC50 = 0.58 microgram/ml) and global score (Emax set at 5.0 by limits of scale, EC50 = 2.53 micrograms/ml). A linear model best described the relationship between predicted effect site concentration and timed walking. L-DOPA plasma concentrations after oral Sinemet did not correlate well with clinical response because clinical response lags behind plasma concentrations. Half-times for equilibration between plasma and the effect site were similar for all of the effects measured.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0362-5664
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
91-7
|
pubmed:dateRevised |
2009-10-6
|
pubmed:meshHeading |
pubmed-meshheading:2720699-Adult,
pubmed-meshheading:2720699-Aged,
pubmed-meshheading:2720699-Carbidopa,
pubmed-meshheading:2720699-Drug Combinations,
pubmed-meshheading:2720699-Female,
pubmed-meshheading:2720699-Humans,
pubmed-meshheading:2720699-Levodopa,
pubmed-meshheading:2720699-Male,
pubmed-meshheading:2720699-Mathematics,
pubmed-meshheading:2720699-Middle Aged,
pubmed-meshheading:2720699-Models, Theoretical,
pubmed-meshheading:2720699-Parkinson Disease
|
pubmed:year |
1989
|
pubmed:articleTitle |
Pharmacokinetic and pharmacodynamic modeling of L-dopa plasma concentrations and clinical effects in Parkinson's disease after Sinemet.
|
pubmed:affiliation |
College of Pharmacy and Allied Health, Wayne State University, Detroit, Michigan 48202.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|